| 1A7C | A:33-170,A:281-325,A:350-359 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE |
| 1ANT | L:14-224,L:321-377; I:13-224,I:321-377 | BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN |
| 1AS4 | A:25-193,A:289-342 | CLEAVED ANTICHYMOTRYPSIN A349R |
| 1ATH | B:19-224,B:321-377; A:9-224,A:321-377 | THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS |
| 1ATU | A:23-194,A:290-358 | UNCLEAVED ALPHA-1-ANTITRYPSIN |
| 1AZX | I:14-224,I:321-377; L:12-224,L:321-377 | ANTITHROMBIN/PENTASACCHARIDE COMPLEX |
| 1B3K | A:33-170,A:281-325,A:336-345; C:33-170,C:281-325,C:336-345; B:33-170,B:281-325,B:351-360; D:33-170,D:281-325,D:351-360 | PLASMINOGEN ACTIVATOR INHIBITOR-1 |
| 1BR8 | L:13-224,L:321-377; I:13-224,I:321-377 | IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN |
| 1BY7 | A:2-207,A:310-364 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT |
| 1C5G | A:56-193,A:304-348,A:359-368 | PLASMINOGEN ACTIVATOR INHIBITOR-1 |
| 1D5S | A:23-194,A:290-353 | CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER |
| 1DB2 | A:33-170,A:281-325,A:336-345; B:33-170,B:281-325,B:351-360 | CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR-1 |
| 1DVM | A:33-170,A:281-325,A:336-346; D:33-170,D:281-325,D:340-349; B:33-170,B:281-325,B:347-356; C:33-170,C:281-325,C:347-356 | ACTIVE FORM OF HUMAN PAI-1 |
| 1DVN | A:33-170,A:281-325,A:336-345 | LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) |
| 1DZG | L:13-224,L:321-377; I:12-224,I:321-377 | N135Q-S380C-ANTITHROMBIN-III |
| 1DZH | L:12-224,L:321-377; I:12-224,I:321-377 | P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III |
| 1E03 | I:14-224,I:321-377; L:11-224,L:321-377 | PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE |
| 1E04 | I:12-224,I:321-377; L:12-224,L:321-377 | PLASMA BETA ANTITHROMBIN-III |
| 1E05 | L:12-224,L:321-377; I:12-224,I:321-377 | PLASMA ALPHA ANTITHROMBIN-III |
| 1EZX | A:24-194,A:290-358 | CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX |
| 1HP7 | A:23-194,A:290-358 | A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS |
| 1IMV | A:29-192,A:300-341 | 2.85 A CRYSTAL STRUCTURE OF PEDF |
| 1IZ2 | A:24-194,A:290-358 | INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING |
| 1JMJ | A:101-278,A:378-426; B:101-278,B:378-426 | CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II |
| 1JMO | A:101-278,A:378-426 | CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX |
| 1JRR | A:2-207,A:310-364 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP |
| 1JVQ | L:12-224,L:321-377; I:12-224,I:321-377 | CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN, A P14-P8 REACTIVE LOOP PEPTIDE, AND AN EXOGENOUS TETRAPEPTIDE |
| 1KCT | A:23-194,A:290-343 | ALPHA1-ANTITRYPSIN |
| 1LJ5 | A:1-170,A:281-325,A:336-345 | 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1) |
| 1LK6 | L:12-224,L:321-377; I:12-224,I:321-377 | STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE |
| 1LQ8 | A:26-189,A:285-338; E:26-189,E:285-338; G:26-189,G:285-338; C:27-189,C:285-338 | CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR |
| 1NQ9 | I:14-224,I:321-377; L:12-224,L:321-377 | CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE |
| 1OC0 | A:6-170,A:281-325,A:336-348 | PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN |
| 1OO8 | A:24-194,A:290-358 | CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION |
| 1OPH | A:23-194,A:290-358 | NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN |
| 1OYH | I:12-224,I:321-377; L:13-224,L:321-377 | CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN |
| 1PSI | A:23-194,A:290-358 | INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU |
| 1QLP | A:23-194,A:290-343 | 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS |
| 1QMN | A:26-193,A:289-342 | ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION) |
| 1R1L | L:12-224,L:321-377; I:12-224,I:321-377 | STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF) |
| 1SR5 | A:14-224,A:321-377 | ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE |
| 1T1F | A:12-224,A:321-377; B:12-224,B:321-377; C:12-224,C:321-377 | CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM |
| 1TB6 | I:12-224,I:321-377 | 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX |
| 1WZ9 | A:1-169,A:276-327; B:1-169,B:276-327 | THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN |
| 1XQG | A:-2-169,A:276-327; B:-2-169,B:276-327 | 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP P 4 21 2 |
| 1XQJ | A:-2-169,A:276-327 | 3.10 A CRYSTAL STRUCTURE OF MASPIN, SPACE GROUP I 4 2 2 |
| 1XU8 | A:0-169,A:276-327; B:0-169,B:276-327 | THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN |
| 2ACH | A:24-193,A:289-342 | CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS |
| 2ANT | L:11-224,L:321-377; I:13-224,I:321-377 | THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE |
| 2ARQ | A:3-207,A:310-364 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH |
| 2ARR | A:3-207,A:310-364 | HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH |
| 2B4X | L:12-224,L:321-377; I:5-224,I:321-380 | CRYSTAL STRUCTURE OF ANTITHROMBIN-III |
| 2B5T | I:12-224,I:321-377 | 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN, SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES |
| 2BEH | I:12-224,I:321-377; L:12-224,L:321-377 | CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN |
| 2CEO | A:20-190,A:287-340; B:20-190,B:287-340 | THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE |
| 2D26 | A:23-194,A:290-358 | ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX |
| 2GD4 | C:9-224,C:321-377; I:9-224,I:321-377 | CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX |
| 2HI9 | A:25-189,A:285-338; C:25-188,C:286-338; B:27-189,B:285-338 | CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR |
| 2HIJ | L:12-224,L:321-377; I:9-224,I:321-377 | CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN |
| 2OL2 | B:27-189,B:285-338; A:28-189,A:285-338 | HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21 |
| 2QUG | A:24-194,A:290-343 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN, CRYSTAL FORM A |
| 2RIV | A:17-190,A:287-355 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN |
| 2RIW | A:19-190,A:287-355 | THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE |
| 2VDX | A:16-184,A:280-333; B:16-184,B:280-333 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN |
| 2VDY | A:16-184,A:280-333; B:16-184,B:280-333 | CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL |
| 3B9F | I:28-189,I:285-338 | 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX |
| 3CAA | A:27-193,A:289-342 | CLEAVED ANTICHYMOTRYPSIN A347R |
| 3CVM | A:0-170,A:281-325,A:336-338; B:0-170,B:281-325,B:336-338 | HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM |
| 3CWL | A:23-194,A:290-343 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN, CRYSTAL FORM B |
| 3CWM | A:24-194,A:290-343 | CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE |
| 3DLW | A:24-193,A:291-344 | ANTICHYMOTRYPSIN |
| 3DRM | A:24-194,A:290-343 | 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1-ANTITRYPSIN |
| 3DRU | B:23-194,B:290-343; C:23-194,C:290-343; A:24-194,A:290-343 | CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN |
| 3DY0 | A:26-189,A:285-338 | CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN |
| 3EOX | A:33-170,A:281-325,A:343-360 | HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB |
| 3F02 | B:24-192,B:295-362; A:24-192,A:295-362 | CLEAVED HUMAN NEUROSERPIN |
| 4CAA | A:28-193,A:289-342 | CLEAVED ANTICHYMOTRYPSIN T345R |
| 7API | A:23-194,A:290-358 | THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM |
| 8API | A:23-194,A:290-358 | THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN, STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM |
| 9PAI | A:19-188,A:299-343,A:354-364 | CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1 |
)
)